Nam T J, Busby W H, Clemmons D R
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill 27599, USA.
Endocrinology. 1996 Dec;137(12):5530-6. doi: 10.1210/endo.137.12.8940380.
We previously reported that human fibroblasts secrete a protease into their conditioned medium that cleaves insulin-like growth factor binding protein-5 (IGFBP-5) into non-IGF-I binding fragments. Because the protease activity in the fibroblast medium has characteristics of both serine and metalloproteases, the activity was purified and analyzed to determine whether it retained serine or metalloprotease properties. The protease was purified by heparin Sepharose affinity chromatography followed by alpha1 antichymotrypsin affinity or gelatin agarose chromatography. The heparin Sepharose purified material degraded IGFBP-5 into 22-, 17-, and 16-kDa fragments. Amino acid sequencing showed that the 22-kDa fragment contained the amino-terminus of the protein. The protease activity in the fibroblast conditioned medium that was purified by heparin Sepharose was inhibited by both serine and metalloprotease inhibitors. To attempt to separate these activities, the heparin Sepharose purified activity was further purified by gelatin agarose chromatography. The IGFBP-5 protease activity that did not bind to gelatin agarose was inhibited by serine protease inhibitors, such as 3,4 dichloroisocoumain (3,4 DCI), whereas tissue inhibitor metalloprotease-1 (TIMP-1) had minimal activity. When this same pool of protease activity that had been eluted from heparin Sepharose was applied to an alpha1 antichymotrypsin peptide affinity column, the protease activity that bound to the column was inhibited by 3,4 dichloroisocoumain, but was not inhibited by TIMP-1. In contrast, the activity that did not adhere to this column was inhibited by TIMP-1. IGFBP-5 zymography showed that the Mr estimate of the protease that was inhibited by serine protease inhibitors was 92 kDa, whereas gelatin zymography showed that the metalloproteases had Mr estimates of 72, 69, and 55 kDa. When the protease activity in the crude conditioned medium was analyzed by zymography, almost all of the detectable protease had an Mr estimate of 92 kDa, suggesting that the metalloproteases that were detected in the partially purified fractions were inactive in the medium. In summary, fibroblasts secrete a 92-kDa protease that cleaves IGFBP-5 into 22-, 17-, and 16-kDa fragments. The protease inhibitor specificity results, chromatographic characteristics, and zymographic analyses suggest that this is a serine protease. Although metalloproteases are secreted by these cells, the 92-kDa serine protease is the predominate form of activity in the conditioned medium that cleaves IGFBP-5.
我们之前报道过,人类成纤维细胞会向其条件培养基中分泌一种蛋白酶,该蛋白酶可将胰岛素样生长因子结合蛋白-5(IGFBP-5)切割成不与IGF-I结合的片段。由于成纤维细胞培养基中的蛋白酶活性具有丝氨酸蛋白酶和金属蛋白酶的特征,因此对该活性进行了纯化和分析,以确定其是否保留丝氨酸或金属蛋白酶的特性。通过肝素琼脂糖亲和层析,随后进行α1抗胰凝乳蛋白酶亲和或明胶琼脂糖层析来纯化该蛋白酶。肝素琼脂糖纯化的物质将IGFBP-5降解为22 kDa、17 kDa和16 kDa的片段序列显示,22 kDa的片段包含该蛋白的氨基末端。经肝素琼脂糖纯化的成纤维细胞条件培养基中的蛋白酶活性受到丝氨酸蛋白酶抑制剂和金属蛋白酶抑制剂的抑制。为了尝试分离这些活性,将经肝素琼脂糖纯化的活性通过明胶琼脂糖层析进一步纯化。不与明胶琼脂糖结合的IGFBP-5蛋白酶活性受到丝氨酸蛋白酶抑制剂如3,4-二氯异香豆素(3,4 DCI)的抑制,而金属蛋白酶组织抑制剂-1(TIMP-1)的抑制作用最小。当将从肝素琼脂糖洗脱的同一批蛋白酶活性应用于α1抗胰凝乳蛋白酶肽亲和柱时,与该柱结合得蛋白酶活性受到3,4-二氯异香豆素的抑制,但不受TIMP-1的抑制。相反,不与该柱结合的活性受到TIMP-1的抑制。IGFBP-5酶谱分析显示,受丝氨酸蛋白酶抑制剂抑制的蛋白酶的分子量估计值为92 kDa,而明胶酶谱分析显示,金属蛋白酶的分子量估计值为72 kDa、69 kDa和55 kDa。当通过酶谱分析粗条件培养基中的蛋白酶活性时,几乎所有可检测到的蛋白酶的分子量估计值为92 kDa,这表明在部分纯化级分中检测到的金属蛋白酶在培养基中无活性。总之,成纤维细胞分泌一种92 kDa的蛋白酶,该蛋白酶可将IGFBP-5切割成22 kDa、17 kDa和16 kDa的片段。蛋白酶抑制剂特异性结果、色谱特征和酶谱分析表明,这是一种丝氨酸蛋白酶。尽管这些细胞会分泌金属蛋白酶,但92 kDa的丝氨酸蛋白酶是条件培养基中切割IGFBP-5的主要活性形式。